Mercado de vacunas para la acuicultura: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00005403
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 190
Buy Now

[Informe de investigación] Se espera que el mercado de vacunas para la acuicultura crezca de 245,13 millones de dólares en 2021 a 569,72 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 12,9 % entre 2022 y 2028.

En las prácticas de acuicultura, siempre existe la posibilidad de que se produzcan brotes patógenos, lo que afecta la producción agrícola. Las vacunas acuícolas se utilizan para proteger a los peces de cualquier patógeno. La vacunación es una técnica simple, confiable y preventiva de control de enfermedades para la acuicultura.

Perspectivas del mercado

La creciente industria de la acuicultura impulsa el crecimiento del mercado

Según los datos de Según un informe titulado "El estado mundial de la pesca y la acuicultura" publicado por la Organización de las Naciones Unidas para la Alimentación y la Agricultura en 2022, el consumo mundial de alimentos acuáticos, excluidas las algas, ha aumentado más de cinco veces la cantidad consumida hace casi 60 años. El consumo de alimentos acuáticos en todo el mundo aumentó de 28 toneladas métricas en 1961 a ~158 toneladas métricas en 2019. El consumo aumentó a una tasa anual promedio del 3,0 % desde 1961, en comparación con una tasa de crecimiento poblacional del 1,6 %. El consumo per cápita está aumentando debido al aumento de la oferta, el cambio en las preferencias de los consumidores y el aumento de los ingresos. En 2019, la Organización de las Naciones Unidas para la Agricultura y la Alimentación estimó el consumo per cápita de alimentos acuáticos para 227 países.

En cuanto a la población, los países que consumen menos que el promedio mundial representaron el 54 % de la población mundial. en 2019. El consumo de alimentos acuáticos es mayor en Islandia, las Islas Feroe y las Maldivas, que consumen más de 80 kg de alimentos acuáticos per cápita al año. En 2019, el consumo medio per cápita en todo el mundo fue de 20,5 kg. Esto difería de un promedio de 5,4 kg en los países de bajos ingresos a 26,5 kg en los países de altos ingresos. El creciente consumo de animales acuáticos está acelerando el crecimiento de la industria de la acuicultura. Las vacunas acuícolas reducen las posibilidades de infección y aumentan el rendimiento de los productos. Por lo tanto, la creciente industria de la acuicultura impulsa el crecimiento del mercado de vacunas para la acuicultura.

Perspectivas estratégicas

La creciente prevalencia de enfermedades infecciosas en animales acuáticos ofrecerá amplias oportunidades de mercado durante el período de pronóstico< /h3>

Según el estudio de investigación titulado "Prevalencia de nematodos anisákidos en peces en China: una revisión sistemática y metaanálisis" publicado por la Biblioteca Nacional de Medicina (NLM) en febrero de 2022, los nematodos anisákidos estaban muy extendidos en pescado en toda China con una tasa de incidencia combinada del 45,5%, y el porcentaje de aparición de pescado fresco fue el mayor (58,1%). El este de China tuvo la tasa de prevalencia más alta de nematodos anisakidos (55,3%), mientras que la prevalencia de nematodos anisakidos (76,8%) fue más alta en el Mar de China Oriental. Según los datos publicados en Aquaculture Research & Development Journal, entre 2014 y 2018 se registraron ~219 casos de enfermedades infecciosas en el sector de la acuicultura en fresco. Entre estos, el 74,88% fueron parasitarios, el 12,80% fueron bacterianos, el 1,83% fueron virales y el 10,50% fueron casos que fueron una mezcla de parásitos. y enfermedades bacterianas. Por lo tanto, se espera que la alta prevalencia de enfermedades infecciosas impulse la demanda de vacunas, lo que brindaría oportunidades lucrativas para el mercado de vacunas para la acuicultura en los próximos años.

Tipo de información basada en vacunas

< p>Según el tipo de vacuna, el mercado de vacunas para la acuicultura se segmenta en vacunas vivas, vacunas inactivadas y otras vacunas. El segmento de vacunas inactivadas tuvo la mayor participación de mercado en 2021. Es probable que el mercado del segmento de vacunas vivas crezca al ritmo más alto durante el período de pronóstico.

Mercado de vacunas para la acuicultura, por tipo de vacuna: 2021 y 2028

Perspectivas basadas en especies

El mercado de vacunas para la acuicultura, según especies, se segmenta en tilapia, trucha, salmón, camarones y otros. El segmento del salmón representó la mayor participación del mercado en 2021 y se espera que registre la CAGR más alta del 13,4% durante el período de pronóstico.

Información basada en la ruta de administración

Según la vía de administración, el mercado de vacunas para la acuicultura se segmenta en inyección, inmersión y oral. El segmento de inyección representó la mayor participación del mercado en 2021 y se espera que registre la CAGR más alta del 13,1% durante el período previsto.   

Las empresas adoptan estrategias inorgánicas y orgánicas como fusiones y adquisiciones en el mercado de vacunas para la acuicultura. A continuación se enumeran algunos desarrollos recientes clave del mercado:

  • En noviembre de 2022, Indian Immunologicals Ltd (IIL) se asoció con el Instituto Central de Educación Pesquera (CIFE) para el desarrollo del primer producto pesquero de la India. vacuna comercialmente. La vacuna se desarrollará para proteger a los peces de agua dulce contra enfermedades bacterianas comunes.  
  • En agosto de 2021, Elanco Animal Health Incorporated adquirió Bayer Animal Health. La transacción, valorada en 6.890 millones de dólares, amplió la escala y las capacidades de Elanco, posicionando a la empresa a largo plazo como líder en la atractiva y duradera industria de la salud animal. La transacción agregó varias marcas de ganado ancla, amplió la presencia acuática de la compañía a peces de aguas cálidas y mejoró la cartera global de bioprotección de la compañía.
  • En julio de 2020, Zoetis adquirió Fish Vet Group de Benchmark Holdings, PLC. como una incorporación estratégica a su negocio Pharmaq, que desarrolla y comercializa vacunas para peces y ofrece servicios de vacunación y diagnóstico para acuicultura. La adquisición mejoró el alcance geográfico y la experiencia en diagnóstico y los servicios de pruebas, incluidas las pruebas ambientales, que el laboratorio de referencia de Pharmaq, Pharmaq Analytiq, puede ofrecer a los piscicultores en los principales mercados de la acuicultura.     

Perfiles de la empresa

  • AquaTactics Fish Health
  • HIPRA SA
  • Merck & Co Inc
  • Microsynbiotix Ltd
  • Indian Immunologicals Ltd
  • Nisseiken Co Ltd
  • Zoetis Inc
  • VETERQUIMICA SA< /li>
  • Phibro Animal Health Corp
  • Elanco Animal Health Inc
  • Tecnovax SA
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the aquaculture vaccines market?

The vaccine is used to establish or improve the immunity against a specific disease or group of diseases. In aquaculture practices, there is always a chance of pathogenic outbreaks, which will affect the production of the farm. Aquaculture vaccines are used to protect the fishes from any pathogen. Vaccination is a simple, reliable, and preventative technique of disease for aquaculture.

What are the driving factors for the aquaculture vaccines market across the world?

The factors driving the aquaculture vaccines market growth, includes growing aquaculture industry and the surging demand for aquatic animal-derived food products. However, strict regulatory policies for the approval of vaccines and the high cost of vaccines hinder the aquaculture vaccines market growth.

Who are the major players in the aquaculture vaccines market?

The aquaculture vaccines market majorly consists of the players, such as AquaTactics Fish Health, HIPRA SA, Merck & Co Inc, Microsynbiotix Ltd, Indian Immunologicals Ltd, Nisseiken Co Ltd, Zoetis Inc, VETERQUIMICA SA, Phibro Animal Health Corp, and Elanco Animal Health Inc.

What will be the CAGR of the aquaculture vaccines market during the forecast period?

The market is estimated to grow at a CAGR of 12.9% during the forecast period.

What was the estimated aquaculture vaccines market size in 2021?

The aquaculture vaccines market was valued at US$ 245.13 million in 2021.

What are the growth estimates for the aquaculture vaccines market till 2028?

The aquaculture vaccines market is expected to be valued at US$ 569.72 million in 2028.

Which segment is dominating the aquaculture vaccines market?

The aquaculture vaccines market, by type of vaccine, is segmented into live vaccines, inactivated vaccines, and other vaccines. The inactivated vaccines segment held the largest market share in 2021. However, live vaccines segment is anticipated to register the highest CAGR in the market during the forecast period.

The List of Companies - Aquaculture Vaccines Market

  1. AquaTactics Fish Health
  2. HIPRA SA
  3. Merck & Co Inc.
  4. Microsynbiotix Ltd
  5. Indian Immunologicals Ltd
  6. Nisseiken Co Ltd
  7. Zoetis Inc.
  8. VETERQUIMICA SA
  9. Phibro Animal Health Corp
  10. Elanco Animal Health Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports